New Key Statistics Module, Z-Score and F-Score
NAS:TVTX Key Ratios
| Market Cap $ M | 1,490.90 |
| Enterprise Value $ M | 1,615.89 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 6.51 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 203.00 |
| EPS (TTM) $ | -4.55 |
| Beneish M-Score | -2.16 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -19.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.79 |
| EV-to-EBITDA | -5.08 |
| PEG | -- |
| Shares Outstanding M | 87.03 |
| Net Margin (%) | -172.75 |
| Operating Margin % | -169.53 |
| Pre-tax Margin (%) | -171.40 |
| Quick Ratio | 1.68 |
| Current Ratio | 1.71 |
| ROA % (ttm) | -52.60 |
| ROE % (ttm) | -325.82 |
| ROIC % (ttm) | -158.27 |
| Dividend Yield % | -- |
| Altman Z-Score | -3.66 |
TVTX Number of Guru Trades
TVTX Volume of Guru Trades
Gurus Latest Trades with NAS:TVTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TVTX is held by these investors
Total 1
Travere Therapeutics Inc Insider Transactions
No Available Data
News about NAS:TVTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers